KNSA vs. VIST
KNSA (Kiniksa Pharmaceuticals, Ltd.) and VIST (Vista Oil & Gas, S.A.B. de C.V.) are both stocks. KNSA operates in Biotechnology (Healthcare), while VIST operates in Oil & Gas E&P (Energy). Over the past 5 years, KNSA returned 29.69%/yr vs 78.91%/yr for VIST. At a 0.14 correlation, their price movements are largely independent.
Performance
KNSA vs. VIST - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, KNSA achieves a 33.60% return, which is significantly lower than VIST's 40.88% return.
KNSA
- 1D
- 1.66%
- 1M
- 3.51%
- YTD
- 33.60%
- 6M
- 27.60%
- 1Y
- 93.78%
- 3Y*
- 52.43%
- 5Y*
- 29.69%
- 10Y*
- —
VIST
- 1D
- 0.04%
- 1M
- -9.10%
- YTD
- 40.88%
- 6M
- 47.77%
- 1Y
- 34.17%
- 3Y*
- 41.96%
- 5Y*
- 78.91%
- 10Y*
- —
KNSA vs. VIST - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
KNSA Kiniksa Pharmaceuticals, Ltd. | 33.60% | 108.54% | 12.77% | 17.09% | 27.27% | -33.39% | 59.76% | -10.37% |
VIST Vista Oil & Gas, S.A.B. de C.V. | 40.88% | -10.07% | 83.36% | 88.44% | 193.81% | 108.20% | -67.39% | -4.85% |
Correlation
The correlation between KNSA and VIST is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.01 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.11 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jul 26, 2019 | 0.14 |
The correlation between KNSA and VIST shifts across timeframes, from -0.01 (1 year) to 0.14 (all time), reflecting how their relationship changes across market environments.
Fundamentals
KNSA:
$4.54B
VIST:
$7.56B
KNSA:
$0.92
VIST:
$6.82
KNSA:
59.85
VIST:
10.06
KNSA:
0.58
VIST:
0.08
KNSA:
5.80
VIST:
2.58
KNSA:
7.50
VIST:
2.91
KNSA:
$754.05M
VIST:
$2.90B
KNSA:
$294.06M
VIST:
$1.31B
KNSA:
$101.06M
VIST:
$2.12B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
KNSA vs. VIST — Risk / Return Rank
KNSA
VIST
KNSA vs. VIST - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Kiniksa Pharmaceuticals, Ltd. (KNSA) and Vista Oil & Gas, S.A.B. de C.V. (VIST). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| KNSA | VIST | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.61 | ||
| Sortino ratioReturn per unit of downside risk | +2.02 | ||
| Omega ratioGain probability vs. loss probability | 1.41 | 1.15 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 4.63 | 0.97 | +3.66 |
| Martin ratioReturn relative to average drawdown | 16.35 | 2.27 | +14.08 |
Loading charts...
Drawdowns
KNSA vs. VIST - Drawdown Comparison
The maximum KNSA drawdown since its inception was -83.06%, roughly equal to the maximum VIST drawdown of -81.19%. Use the drawdown chart below to compare losses from any high point for KNSA and VIST.
Loading charts...
Drawdown Indicators
| KNSA | VIST | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.06% | -81.19% | -1.87% |
Max Drawdown (1Y)Largest decline over 1 year | -21.12% | -34.04% | +12.92% |
Max Drawdown (3Y)Largest decline over 3 years | -34.14% | -43.36% | +9.22% |
Max Drawdown (5Y)Largest decline over 5 years | -53.17% | -43.36% | -9.81% |
Current DrawdownCurrent decline from peak | -7.35% | -13.50% | +6.15% |
Average DrawdownAverage peak-to-trough decline | -40.60% | -28.19% | -12.41% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.97% | 14.92% | -8.95% |
Volatility
KNSA vs. VIST - Volatility Comparison
Kiniksa Pharmaceuticals, Ltd. (KNSA) has a higher volatility of 10.40% compared to Vista Oil & Gas, S.A.B. de C.V. (VIST) at 9.16%. This indicates that KNSA's price experiences larger fluctuations and is considered to be riskier than VIST based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| KNSA | VIST | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.40% | 9.16% | +1.24% |
Volatility (6M)Calculated over the trailing 6-month period | 34.02% | 32.64% | +1.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 43.03% | 49.91% | -6.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 53.48% | 52.02% | +1.46% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 63.93% | 61.08% | +2.85% |
Dividends
KNSA vs. VIST - Dividend Comparison
Neither KNSA nor VIST has paid dividends to shareholders.
Financials
KNSA vs. VIST - Financials Comparison
This section allows you to compare key financial metrics between Kiniksa Pharmaceuticals, Ltd. and Vista Oil & Gas, S.A.B. de C.V.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
KNSA vs. VIST - Profitability Comparison
KNSA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a gross profit of 0.00 and revenue of 214.27M. Therefore, the gross margin over that period was 0.0%.
VIST - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a gross profit of 472.36M and revenue of 865.01M. Therefore, the gross margin over that period was 54.6%.
KNSA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported an operating income of 29.27M and revenue of 214.27M, resulting in an operating margin of 13.7%.
VIST - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported an operating income of 216.12M and revenue of 865.01M, resulting in an operating margin of 25.0%.
KNSA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Kiniksa Pharmaceuticals, Ltd. reported a net income of 22.59M and revenue of 214.27M, resulting in a net margin of 10.5%.
VIST - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Vista Oil & Gas, S.A.B. de C.V. reported a net income of 107.71M and revenue of 865.01M, resulting in a net margin of 12.5%.
Frequently Asked Questions
KNSA and VIST have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
KNSA has higher volatility (10.40%) compared to VIST (9.16%). In terms of maximum drawdown, KNSA dropped -83.06% vs VIST's -81.19%.
KNSA currently has the higher Sharpe Ratio (2.27 vs 0.66), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for KNSA and VIST
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer